Qianxiang Zhou - Suzhou Kintor Pharmaceuticals

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 15 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Proxalutamide Reduces SARS- CoV-2 Infection and Associated Inflammatory Response

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAno. 30 (2023)

引用1浏览0WOS引用

Discovery and evaluation of GT19630, a c-Myc/GSPT1 cereblon E3 ligase modulator (CELMoD), for targeting Myc-driven blood cancers and small cell lung cancers (SCLC)

Liandong Ma,Youzhi Tong,Zhaohui Yang,Qianxiang Zhou, Hongha Yan,Ru Xu, Jie Chen, Jie Pan,Huiyuan Wang, Jiangwei Li, Dong Chen, Xiang Cai, Jie Qu,Yini Wang, Jun Qin,Yuki Nishida,Michael Andreeff, Qilnli Guo,Yuki Nishida,Michael Andreeff

CANCER RESEARCHno. 12 (2022)

引用0浏览0引用

Abstract 5479: Discovery and Evaluation of GT19630, a C-Myc/gspt1 Cereblon E3 Ligase Modulator (celmod), for Targeting Myc-driven Blood Cancers and Small Cell Lung Cancers (SCLC)

Cancer Researchno. 12_Supplement (2022): 5479-5479

引用0浏览0引用

AML-147 C-MYC Targeting by Degradation: Novel Dual C-Myc/gspt1 Degrader GT19715 Exerts Profound Cell Kill in Vitro and in Vivo in Acute Myeloid Leukemia and Lymphomas

Yuki Nishida,Darah A. Scruggs,Edward Ayoub,Tallie Patsilevas,Vivian R. Ruvolo,Po Yee Mak,Bing Z. Carter,Steffen Boettcher,Abhishek Maiti,Qianxiang Zhou,Zhaohui Yang,Honghua Yan,Liandong Ma,Michael Andreeff

Clinical lymphoma myeloma & leukemia/Clinical lymphoma, myeloma and leukemia（2022）

引用0浏览0WOS引用

Abstract A03: Discovery and Evaluation of GT19630, a C-Myc/n-myc Degrader, for Targeting C-Myc-driven B-cell Malignancies, Acute Myeloid Leukemia (AML) and N-Myc Driven Cancers

Liandong Ma, Yuzhi Tong,Zhaohui Yang,Qianxiang Zhou,Honghua Yan,Ye Chen, Dong Chen,Ru Xu,Yini Wang, Jun Qin

Blood cancer discoveryno. 5_Supplement (2022): A03-A03

引用0浏览0引用

Abstract 5274: Mechanisms of Action (MOA) for Proxalutamide, an Androgen Receptor (AR) Antagonist, for the Treatment of Mild, Moderate and Severe COVID-19 Patients

Liandong Ma,Youzhi Tong,Qianxiang Zhou, Hongha Yan,Xiaodan Hou, Zhiha Ren, Jiangwei Li,Huiyuan Wang,Weidong Qian, Yu Zhang, Andy Goren,Arul Chinnaiyan

Cancer researchno. 12_Supplement (2022): 5274-5274

引用0浏览0引用

C-MYC Targeting by Degradation: Novel Dual C-Myc/gspt1 Degrader GT19715 Induces TP53-Independent Cell Death in Acute Myeloid Leukemia and Lymphomas

Yuki Nishida,Darah A. Scruggs,Edward Ayoub,Tallie Patsilevas,Vivian Ruvolo,Po Yee Mak,Bing Z. Carter,Steffen Boettcher,Abhishek Maiti,Qianxiang Zhou,Zhaohui Yang,Honghua Yan,Liandong Ma,Michael Andreeff

Blood（2022）

引用1浏览0引用

Inhibitory effects of GT0918 on acute lung injury and the molecular mechanisms of anti-inflammatory response

Xiaodan Hou,Honghua Yan, Ao Wang, Cong Liu,Qianxiang Zhou,Liandong Ma,Jie Chen, Zhihua Ren,Youzhi Tong

biorxiv（2022）

引用0浏览0引用

Repurposing 2nd Generation Androgen Receptor Antagonist Proxalutamide to Treat COVID-19

Long M.D.,Youzhi Tong, Qiaozhi Guo,Ye Zhou,Qianxiang Zhou,Honghua Yan

Cancer research（2021）

引用0浏览0引用

Abstract 1265: Discovery of GT19077, a C-Myc/max Protein-Protein Interaction (PPI) Small Molecule Inhibitor, and GT19506 a C-Myc PROTAC Molecule, for Targeting C-Myc-driven Blood Cancers and Small Cell Lung Cancers

Liandong Ma,Youzhi Tong,Qianxiang Zhou,Zhaohui Yang, Honghau Yan,Ye Chen, XU Ruo,Jie Pan, Xiaoqi Gou,Weidong Qian,Jie Chen,Qi Sun,Luhua Lai

Cancer researchno. 13_Supplement (2021): 1265-1265

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn